Search
Immatics NV
IMTXAdd to Watchlist
9.857USD
+0.007+0.07%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.35BMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-01 The current financial score of Immatics NV is 7.45, ranking 119 out of 387 in the Biotechnology & Medical Research industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 8.93M, representing a year-over-year decrease of 57.01%, while its net profit experienced a year-over-year decrease of 52.23%.
Financials
9.12
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.61
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
3.05
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
9.96
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.51
Free cash flow
Relevant data have not been disclosed by the company yet.